NewsVenture Capital16/07/2020
Relay Therapeutics: The 100-Year Race towards Better Drug Discovery
GV →GV congratulated Relay Therapeutics on its IPO and described investments in 2017 and 2018. The IPO is not treated as a sale of GV’s entire position.